Uliledlimab
Uliledlimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).
| Trade Name | Uliledlimab |
| Generic | Uliledlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Uliledlimab
